LAII Workshop at CRS 2020 Now Available On Demand!

Process Engineering and Scale-Up for Long-Acting Systems

This workshop from the CRS Virtual Annual Meeting 2020 is now available for free. It provides the audience with an overview of the processes involved in creating long acting injectable (LAI) products. Viewers will explore the scientific disciplines and engineering approaches for scale up and processing of nano- and micro-particles for long-acting injectables as well as hot melt extrusion methodology for implants. The process parameters and challenges of scale up of these technologies will be addressed.

Speakers

Christopher A. Rhodes, Ph.D.

President & CEO
Drug Delivery Experts
Workshop Chair & Moderator

Particle Processing and PK Outcomes

Rennan Pan, PhD

Director
GlaxoSmithKline

Rennan Pan joined GlaxoSmithKline in 2000 and is currently a Team Director in R&D Pharmaceutical Development at GSK.  Since 2009, Rennan has led the drug product development for cabotegravir long acting injectable suspension from preclinical development, clinical development, NDA/MAA submission and approval, to product launch.  Prior to GSK, Rennan worked at FMC for 4 years.  Rennan is a subject matter expert on long acting injectables, oral controlled release formulations and oral immediate release tablets.  Rennan has a PhD in Chemical Engineering from the City University of New York.

Application of IVIVC/IVIVR in Development of LAI Aqueous Crystalline Suspensions

Noor Al-Rifai, Ph.D.

Senior Scientist – Drug Product Development
Janssen Pharmaceutical Companies of Johnson & Johnson
Process Development and Technology Transfer for Top-Down Production of Nano- and Micro-Suspensions

James Arps, Ph.D.

Technical Director
ProMed Pharma
Injection Molded Dosage Forms for Longer-Term Release

Tony Listro

Technical and Business Executive
Foster Delivery Science
Shape of Innovation: Polymer Materials and Processing Techniques for Long Term Implantable Dosage Forms

Andrew Owen, Ph.D.

Professor & Director of the Centre of Excellence in Long-Acting Therapeutics (CELT)
University of Liverpool
Established and Emerging Long-Acting Technologies and Pharmacological Considerations

Presentation & Poster Abstract Submission for LAII 2021

We are currently accepting presentation & poster abstracts for next year's meeting. Please leave your name, email, your talk/poster title, and abstract below:

Previous Events: